Resona Asset Management Co.,Ltd. Neurocrine Biosciences Inc Transaction History
Resona Asset Management Co.,Ltd.
- $20 Billion
- Q2 2025
A detailed history of Resona Asset Management Co.,Ltd. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Resona Asset Management Co.,Ltd. holds 52,548 shares of NBIX stock, worth $7.83 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
52,548
Previous 50,967
3.1%
Holding current value
$7.83 Million
Previous $5.64 Million
17.18%
% of portfolio
0.03%
Previous 0.03%
Shares
6 transactions
Others Institutions Holding NBIX
# of Institutions
678Shares Held
102MCall Options Held
290KPut Options Held
214K-
Black Rock Inc. New York, NY14.2MShares$2.11 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.81MShares$1.46 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.57MShares$829 Million0.42% of portfolio
-
State Street Corp Boston, MA4.47MShares$666 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.09MShares$460 Million0.04% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $14.2B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...